Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (291-300 of 426) with videos related to

Pageof 43
Sort By:
Diabetes, Obesity & Metabolism|April 16, 2019
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective studyGian Paolo Fadini, Veronica Sciannameo, Ivano Franzetti, et al.
Diabetes|March 26, 2015
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin MMattia Albiero, Nicol Poncina, Stefano Ciciliot, et al.
Journal of Clinical Medicine|August 10, 2024
Renal Replacement Therapy in Methylmalonic Aciduria-Related Metabolic Failure: Case Report and Literature ReviewGiovanni Pintus, Nicola Vitturi, Gianni Carraro, et al.
Diabetes Research and Clinical Practice|February 6, 2021
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine careBenedetta Maria Bonora, Mauro Rigato, Vera Frison, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2016
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet CulturesValentina Scattolini, Camilla Luni, Alessandro Zambon, et al.
Diabetes, Obesity & Metabolism|August 1, 2019
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness studyMario Luca Morieri, Mauro Rigato, Vera Frison, et al.
Stroke|March 3, 2007
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI studyCarlo Bruno Giorda, Angelo Avogaro, Marina Maggini, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian familyGiuseppe Maiolino, Stefania Colonna, Mario Zanchetta, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 11, 2016
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet CulturesValentina Scattolini, Camilla Luni, Alessandro Zambon, et al.
Acta Diabetologica|November 2, 2019
Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast ItalyGian Paolo Fadini, Vera Frison, Mauro Rigato, et al.
Pageof 43

Showing results (291-300 of 426) with videos related to

Sort By:
Pageof 43
Diabetes, Obesity & Metabolism|April 16, 2019
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective studyGian Paolo Fadini, Veronica Sciannameo, Ivano Franzetti, et al.
Diabetes|March 26, 2015
Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin MMattia Albiero, Nicol Poncina, Stefano Ciciliot, et al.
Journal of Clinical Medicine|August 10, 2024
Renal Replacement Therapy in Methylmalonic Aciduria-Related Metabolic Failure: Case Report and Literature ReviewGiovanni Pintus, Nicola Vitturi, Gianni Carraro, et al.
Diabetes Research and Clinical Practice|February 6, 2021
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine careBenedetta Maria Bonora, Mauro Rigato, Vera Frison, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 1, 2016
Erratum to: Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet CulturesValentina Scattolini, Camilla Luni, Alessandro Zambon, et al.
Diabetes, Obesity & Metabolism|August 1, 2019
Fixed versus flexible combination of GLP-1 receptor agonists with basal insulin in type 2 diabetes: A retrospective multicentre comparative effectiveness studyMario Luca Morieri, Mauro Rigato, Vera Frison, et al.
Stroke|March 3, 2007
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI studyCarlo Bruno Giorda, Angelo Avogaro, Marina Maggini, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|April 1, 2011
Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian familyGiuseppe Maiolino, Stefania Colonna, Mario Zanchetta, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 11, 2016
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet CulturesValentina Scattolini, Camilla Luni, Alessandro Zambon, et al.
Acta Diabetologica|November 2, 2019
Trend 2010-2018 in the clinical use of GLP-1 receptor agonists for the treatment of type 2 diabetes in routine clinical practice: an observational study from Northeast ItalyGian Paolo Fadini, Vera Frison, Mauro Rigato, et al.
Pageof 43